2023
DOI: 10.1016/j.xplc.2022.100512
|View full text |Cite
|
Sign up to set email alerts
|

MEP pathway products allosterically promote monomerization of deoxy-D-xylulose-5-phosphate synthase to feedback-regulate their supply

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(15 citation statements)
references
References 46 publications
0
9
0
Order By: Relevance
“…DXPS is active as a homodimer. A recent study suggests that DXPS activity is regulated via ligand-induced changes to the oligomeric state . To determine the effect of 8 on quaternary structure, we conducted native polyacrylamide gel electrophoresis (PAGE) and analytical gel filtration (aGF) analyses.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…DXPS is active as a homodimer. A recent study suggests that DXPS activity is regulated via ligand-induced changes to the oligomeric state . To determine the effect of 8 on quaternary structure, we conducted native polyacrylamide gel electrophoresis (PAGE) and analytical gel filtration (aGF) analyses.…”
Section: Resultsmentioning
confidence: 99%
“…Interestingly, analog 8 appears to shift the DXPS oligomer equilibrium, inducing higher-order oligomeric states. Di et al have recently reported ligand-induced monomerization of DXPS by downstream MEP pathway intermediates, 81 suggesting DXPS regulation by reversible reduction of DXPS dimer activity. Although the activity of the higher-order tetramer is unknown, it is conceivable that shifting the oligomer equilibrium could contribute to the inhibitory activity of this enzyme class.…”
Section: ■ Discussionmentioning
confidence: 99%
“…These efforts relied on augmentation of the endogenous MEP pathway by overexpressing key enzymes; however, titers were limited. Recent studies have demonstrated a conserved, allosteric regulatory mechanism where 1-deoxy-D-xylulose-5-phosphate synthase (DXS), the rate-limiting MEP enzyme, forms inactive aggregates when IPP and DMAPP levels are high (Banerjee and Sharkey 2014; Di et al 2023). The subsequent downregulation of the MEP pathway may be a source of the low titers achieved in the previous C. glutamicum monoterpene production studies.…”
Section: Resultsmentioning
confidence: 99%
“…Lim, Park, and Woo 2020; Li, Xu, and Lu 2021) . Each of these efforts relied upon the overexpression of key components [typically deoxyxylulose 5-phosphate synthase ( dxs ) and isopentenyl diphosphate isomerase ( idi )] within the native MEP pathway, which is subject to endogenous regulation that may limit the isoprenyl precursors, IPP and DMAPP (Banerjee and Sharkey 2014; Li, Xu, and Lu 2021; Kang et al 2014; Di et al 2023). To overcome these potential limitations, (Sasaki et al 2019) leveraged a heterologous MVA-based, episomal bypass pathway to produce isoprenol at titers over 1000 mg/L, providing a promising foundation toward high production for other isoprenoids.…”
Section: Introductionmentioning
confidence: 99%
“…The change in the rate of DXP turnover, but not in its pool size, likely reflects the role of DXS as the major rate determining step of the MEP pathway 28 , which increases the rate of flux through the pathway when substrate concentrations rise. DXS is also under allosteric 29,30 and proteolytic regulation 31 . The subsequent step, catalyzed by DXP reductoisomerase (DXR), is evidently able to keep up with the increased rate of DXP production and maintain DXP levels constant.…”
Section: Main Textmentioning
confidence: 99%